Skip to content

National epidemiological investigation and registration system development and application for tracheobronchial tuberculosis

Novel strategy of precise diagnosis and treatment for tracheobronchial tuberculosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023267
Enrollment
Unknown
Registered
2019-05-19
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tracheobronchial tuberculosis

Interventions

tuberculosis group:bronchoscopy

Sponsors

Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with pulmonary tuberculosis between the ages of 16 and 65 years; 2. Be conscious and fluent in speech, with compliance to the treatment; 3. Give voluntary, signed informed consent in accordance with institutional policies.

Exclusion criteria

Exclusion criteria: 1. Irreversible contraindications of bronchoscopic examinations; 2. Asymptomatic inactive tuberculosis; 3. Comorbidities of the cardiovascular, liver, renal and hematopoietic system, psychiatric disorders and other other medical, psychosocial, or emotional conditions that adversely affect life quality; 4. Currently participation in other interventional clinical trials.

Design outcomes

Primary

MeasureTime frame
lung function test;bronchoscopic findings;

Secondary

MeasureTime frame
mMRC;6-minute walking distance;chest CT scan;

Countries

China

Contacts

Public ContactShuliang Guo

Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University

guosl999@sina.com+86 13101363078

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026